Safety of AS03-adjuvanted influenza vaccines: A review of the evidence
Safety of AS03-adjuvanted influenza vaccines: A review of the evidence
About this item
Full title
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
•Non-clinical studies raised no safety concerns regarding the use of AS03.•In clinical trials, AS03-adjuvanted influenza vaccines were generally well tolerated.•Post-licensure data showed a favourable benefit-risk profile in various populations.•The increased risk of narcolepsy with Pandemrix may not be directly linked to AS03.•Available safety dat...
Alternative Titles
Full title
Safety of AS03-adjuvanted influenza vaccines: A review of the evidence
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2220723599
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2220723599
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2019.04.048
